Literature DB >> 16132359

(99m)Tc-EC-guanine: synthesis, biodistribution, and tumor imaging in animals.

David J Yang1, Kaoru Ozaki, Chang-Sok Oh, Ali Azhdarinia, Thomas Yang, Megumi Ito, Allison Greenwell, Jerry Bryant, Saady Kohanim, Vincenzo K Wong, E Edmund Kim.   

Abstract

PURPOSE: DNA markers are useful in assessing cell proliferation. The purpose of this study was to synthesize (99m)Tc-ethylenedicysteine-guanine (EC-Guan) for evaluation of cell proliferation.
METHODS: Tumor cells were incubated with (99m)Tc-EC-Guan for cell cycle analysis. Prostate tumor cells that were overexpressing the HSV thymidine kinase gene, or various tumor cells were incubated with (99m)Tc-EC-Guan at 0.5-2 h. Thymidine incorporation assays were performed in lung cancer cells incubated with EC-Guan at 0.1-1 mg/well. Tissue distribution, autoradiography, and planar scintigraphy of (99m)Tc-EC-Guan and (99m)Tc-EC (control) were determined in tumor-bearing rodents at 0.5-4 h.
RESULTS: Cell culture assays indicated that EC-Guan was incorporated in DNA, and there was no significant uptake difference between HSVTK overexpressed and normal groups. Biodistribution and scintigraphic imaging studies of (99m)Tc-EC-Guan showed increased tumor/tissue count density ratios as a function of time.
CONCLUSIONS: Our results indicate that (99m)Tc-EC-Guan may be useful as a tumor proliferation imaging agent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132359     DOI: 10.1007/s11095-005-6157-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  33 in total

1.  99mTc-ethylenedicysteine-folate: a new tumor imaging agent. Synthesis, labeling and evaluation in animals.

Authors:  S Ilgan; D J Yang; T Higuchi; F Zareneyrizi; H Bayhan; D Yu; E E Kim; D A Podoloff
Journal:  Cancer Biother Radiopharm       Date:  1998-12       Impact factor: 3.099

2.  Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.

Authors:  K Ohtsuki; K Akashi; Y Aoka; F G Blankenberg; S Kopiwoda; J F Tait; H W Strauss
Journal:  Eur J Nucl Med       Date:  1999-10

3.  Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole.

Authors:  D J Yang; S Ilgan; T Higuchi; F Zareneyrizi; C S Oh; C W Liu; E E Kim; D A Podoloff
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

4.  Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate.

Authors:  L Malspeis; M R Grever; A E Staubus; D Young
Journal:  Semin Oncol       Date:  1990-10       Impact factor: 4.929

5.  Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression.

Authors:  Juri Gelovani Tjuvajev; Mikhail Doubrovin; Timothy Akhurst; Shangde Cai; Julius Balatoni; Mian M Alauddin; Ronald Finn; William Bornmann; Howard Thaler; Peter S Conti; Ronald G Blasberg
Journal:  J Nucl Med       Date:  2002-08       Impact factor: 10.057

6.  Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, and 18F-5-fluorodeoxyuridine in animals.

Authors:  Y Abe; H Fukuda; K Ishiwata; S Yoshioka; K Yamada; S Endo; K Kubota; T Sato; T Matsuzawa; T Takahashi; T Ido
Journal:  Eur J Nucl Med       Date:  1983

7.  Using Tc-99m DMSA renal cortex scan to detect renal damage in women with type 2 diabetes.

Authors:  Hsi-Chin Wu; Chao-Hsiang Chang; Ming-May Lai; Cheng-Chieh Lin; Cheng-Chun Lee; Albert Kao
Journal:  J Diabetes Complications       Date:  2003 Sep-Oct       Impact factor: 2.852

8.  Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity.

Authors:  J Okada; K Yoshikawa; M Itami; K Imaseki; K Uno; J Itami; J Kuyama; A Mikata; N Arimizu
Journal:  J Nucl Med       Date:  1992-03       Impact factor: 10.057

9.  Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67.

Authors:  K Kubota; K Ishiwata; R Kubota; S Yamada; M Tada; T Sato; T Ido
Journal:  J Nucl Med       Date:  1991-11       Impact factor: 10.057

10.  The uptake of 3'-deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels.

Authors:  Henryk Barthel; Meg Perumal; John Latigo; Qimin He; Frank Brady; Sajinder K Luthra; Pat M Price; Eric O Aboagye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-09-04       Impact factor: 9.236

View more
  3 in total

1.  Molecular imaging of Bcr-Abl phosphokinase in a xenograft model.

Authors:  Ji Yuan Wu; David J Yang; Laura S Angelo; Saady Kohanim; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2009-03-03       Impact factor: 6.261

2.  Molecular imaging of mesothelioma with (99m)Tc-ECG and (68)Ga-ECG.

Authors:  Yin-Han Zhang; Jerry Bryant; Fan-Lin Kong; Dong-Fang Yu; Richard Mendez; E Edmund Kim; David J Yang
Journal:  J Biomed Biotechnol       Date:  2012-05-08

3.  Enhanced tumor uptake, biodistribution and pharmacokinetics of etoposide loaded nanoparticles in Dalton's lymphoma tumor bearing mice.

Authors:  Movva Snehalatha; Venugopal Kolachina; Ranendra Narayan Saha; Anil Kumar Babbar; Navneet Sharma; Rakesh Kumar Sharma
Journal:  J Pharm Bioallied Sci       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.